Clinical trial
Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by…
NCT00022139 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00022139 |
|---|---|
| Title | Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction |
| Official title | A Phase II Trial of Preoperative Radiation and Chemotherapy (Paclitaxel, Carboplatin, and Continuous Infusion 5-FU) for Locally Advanced Esophageal Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carboplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy |
| Enrollment | 56 |
| Start date | Jan 1, 2002 |
| Primary completion | Jul 1, 2005 |
| Completion | Jan 1, 2009 |
| First posted | Mar 7, 2003 |
| Last update posted | Dec 7, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: